Prelude Therapeutics Inc (PRLD)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -178.959 | -144.055 | -46.385 | -42.253 | -43.926 | -48.912 |
| Return on Equity (%) | 129.379 | 76.472 | -69.95 | -44.85 | -47.966 | -56.335 |
| Return on Invested Capital (%) | -215.437 | -181.741 | -51.341 | -46.1 | -52.844 | -63.174 |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | 5.05 | 4.657 | 2.427 | 3.003 | 2.04 | 2.16 |
| Earnings Per Share | -5.332 | -7.539 | -0.651 | -1.173 | -1.205 | -1.11 |
| Cash Per Share | 5.665 | 5.162 | 2.498 | 0.334 | 0.319 | 0.23 |
| Working Capital Per Share | 4.776 | 4.208 | 2.396 | 2.898 | 1.907 | 1.948 |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | -5.332 | -7.539 | -0.651 | -1.173 | -1.205 | -1.11 |
| EBITDA Per Share | -5.332 | -7.539 | -0.651 | -1.173 | -1.205 | -1.11 |
| Free Cash Flow Per Share | -5.177 | -7.43 | -0.65 | -1.158 | -1.187 | -1.089 |
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Current Ratio | 6.373 | 4.183 | 19.412 | 15.37 | 9.418 | 10.792 |
| Quick Ratio | 6.373 | 3.905 | 19.192 | 15.168 | 9.295 | 10.671 |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 2.75M | 3.66M | 32.6M | 36.2M | 36.5M | 42.06M |
| Year End December 30 2023 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
| Shares Outstanding | 36.37M | 36.45M | 36.5M | 36.51M | 41.96M | 41.97M | 42.06M | 42.07M |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | 8.914 | N/A | N/A | N/A | 11.64 |
| Quick Ratio | N/A | N/A | N/A | 8.761 | N/A | N/A | N/A | 11.445 |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 208.73M |
| Price to Earnings Ratio | -1.71 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 8.25 |
| Price to Book Ratio | 0.88 |
| Dividend Yield | - |
| Shares Outstanding | 54.93M |
| Average Volume (1 week) | 54.45k |
| Average Volume (1 Month) | 50.24k |
| 52 Week Change | -27.51% |
| 52 Week High | 5.83 |
| 52 Week Low | 1.66 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
